FDA warned Plantacea, doing business as Kahm, about unapproved CBD drugs for humans and animals and adulterated CBD gummies.
What happened
FDA reviewed kahmcbd.com and linked social media in May 2022 and found order-taking and claims for CBD products for humans and animals. FDA said the animal products were unapproved new animal drugs and the human products were unapproved new drugs and misbranded. FDA also said two CBD Gummies flavors were adulterated because they contain an unsafe food additive.
What FDA found
CBD Hemp Pellets and K9 Soft Chews were marketed as unapproved new animal drugs and are unsafe and adulterated.
FD&C Act §§ 512(a), 501(a)(5); 21 U.S.C. §§ 360b(a), 351(a)(5)Kahm CBD products for humans and Tanka products for humans were marketed as unapproved new drugs without an approved application.
FD&C Act §§ 505(a), 301(d); 21 U.S.C. §§ 355(a), 331(d)Kahm CBD products for humans and Tanka products for humans were misbranded because their labeling lacked adequate directions for use.
FD&C Act § 502(f)(1); 21 U.S.C. § 352(f)(1)CBD Gummies in Blue Raspberry and Raspberry flavors were adulterated because they contain CBD, an unsafe food additive.
FD&C Act §§ 402(a)(2)(C)(i), 301(ll); 21 U.S.C. §§ 342(a)(2)(C)(i), 331(ll)CBD Hemp Pellets were labeled for horses and livestock, raising concerns about CBD residues in human food from food-producing animals.
FD&C Act §§ 301(ll), 402(a)(2)(C)(i); 21 U.S.C. §§ 331(ll), 342(a)(2)(C)(i)CBD Broad Spectrum Hemp Extract and Tanka bands were promoted as dietary supplements, but FDA says CBD is excluded and the bands are not intended for ingestion.
FD&C Act §§ 201(ff)(3)(B)(i)-(ii), 201(ff)(2)(A)(i); 21 U.S.C. § 321(ff)(3)(B)(i)-(ii), 321(ff)(2)(A)(i)
What FDA wants
FDA asks the company to take immediate action to stop selling any unapproved CBD products for food-producing animals. The provided letter does not show a response deadline.
Who should pay attention
- CBD and hemp product brands
- retailers selling CBD foods, supplements, or topicals
- makers of horse or livestock supplements
This is a summary. Read the original letter on fda.gov.